about us
Company profile
Xi'an Salis Biological Co., Ltd. was established in 2023, covering an area of approximately 10,000 square meters, with a strategic location and convenient transportation. A high-tech enterprise integrating R&D, production, processing, and sales of natural plant extracts and intermediates. Our brand is synonymous with trust, reliability, and professionalism. We are committed to providing our customers with high-quality API, backed by a deep understanding of the pharmaceutical industry
Xi'an Salis Biological Co. produces a variety of APIs including matrine, niclosamide, ciprofloxacin, ibuprofen, tadalafil, and tadalafil. We can produce customized products according to customer needs and can cooperate to develop new products with good market prospects. The raw materials that have obtained national drug approval numbers include matrine, oxymatrine, and aconitine hydrobromide. In 2014, cytisine received export approval to the EU from the Shaanxi Provincial Food and Drug Administration. The products produced by our company are widely used in medicine, health products, cosmetics, and other fields.
Our Factory
Salis has established a quality system that meets international standards and systematically implements it throughout the entire process of pharmaceutical production, quality control, product release, storage, and transportation. Salis's quality system includes quality control system, quality assurance system and verification system.
factory appearance
equipment
Sample extraction
Our Certificates
Salis has built a high-end biopharmaceutical industrialization base with an area of 100,000 square meters. The construction standards of the industrial production line also meet the requirements of NMPA, and FDA.
At the base, we have a total production capacity of 60,000 liters of macromolecular drugs. The production line has passed the FDA audit. This is one of the few biopharmaceutical production lines in China that meets the US FDA standards. It is also equipped with top-level international and domestic processes. Equipment, analytical instruments, pharmaceutical water, clean air conditioning, public systems and online monitoring systems, and other equipment and facilities.
Our Mission
Developing high-quality biopharmaceuticals is the mission and goal of Salis Biological. Sails is committed to the research and development, production and sales of innovative drugs in the fields of major diseases such as tumors, autoimmunity, metabolism, ophthalmology, etc., so that our work can benefit more lives. While Salis continues to develop innovative drugs and pursue its own development, it remains true to its original aspirations. Over the years, we have always had scientific and benevolent thoughts and actively fulfilled our social responsibilities. The company has successively initiated and participated in a number of pharmaceutical public welfare assistance projects, followed the scientific pace, continued to innovate, and produced high-quality APIs.
